v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Total Edwards Lifesciences Corporation Stockholders' Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Common stock, beginning balance (in shares) at Dec. 31, 2024     654.8          
Beginning balance at Dec. 31, 2024 $ 10,062.9 $ 9,998.4 $ 654.8 $ (6,192.3) $ 2,613.4 $ 13,167.0 $ (244.5) $ 64.5
Treasury stock, beginning balance (in shares) at Dec. 31, 2024       66.2        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 356.4 358.0       358.0   (1.6)
Other comprehensive income (loss), net of tax (10.0) (10.0)         (10.0)  
Common stock issued under stock and equity plans (in shares)     1.1          
Common stock issued under stock and equity plans 50.7 50.7 $ 1.1   49.6      
Stock-based compensation expense 40.2 40.2     40.2      
Purchases of treasury stock (in shares)       3.5        
Purchases of treasury stock (308.6) (308.6)   $ (258.6) (50.0)      
Common stock, ending balance (in shares) at Mar. 31, 2025     655.9          
Ending balance at Mar. 31, 2025 10,191.6 10,128.7 $ 655.9 $ (6,450.9) 2,653.2 13,525.0 (254.5) 62.9
Treasury stock, ending balance (in shares) at Mar. 31, 2025       69.7        
Common stock, beginning balance (in shares) at Dec. 31, 2024     654.8          
Beginning balance at Dec. 31, 2024 10,062.9 9,998.4 $ 654.8 $ (6,192.3) 2,613.4 13,167.0 (244.5) 64.5
Treasury stock, beginning balance (in shares) at Dec. 31, 2024       66.2        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 978.2              
Common stock, ending balance (in shares) at Sep. 30, 2025     658.2          
Ending balance at Sep. 30, 2025 10,205.0 10,205.0 $ 658.2 $ (7,049.5) 2,697.4 14,149.3 (250.4) 0.0
Treasury stock, ending balance (in shares) at Sep. 30, 2025       77.5        
Common stock, beginning balance (in shares) at Mar. 31, 2025     655.9          
Beginning balance at Mar. 31, 2025 10,191.6 10,128.7 $ 655.9 $ (6,450.9) 2,653.2 13,525.0 (254.5) 62.9
Treasury stock, beginning balance (in shares) at Mar. 31, 2025       69.7        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 331.5 333.2       333.2   (1.7)
Other comprehensive income (loss), net of tax (9.6) (9.6)         (9.6)  
Common stock issued under stock and equity plans (in shares)     1.7          
Common stock issued under stock and equity plans 61.0 61.0 $ 1.7   59.3      
Stock-based compensation expense 37.5 37.5     37.5      
Purchases of treasury stock (5.5) (5.5)   $ (5.5)        
Common stock, ending balance (in shares) at Jun. 30, 2025     657.6          
Ending balance at Jun. 30, 2025 10,606.5 10,545.3 $ 657.6 $ (6,456.4) 2,750.0 13,858.2 (264.1) 61.2
Treasury stock, ending balance (in shares) at Jun. 30, 2025       69.7        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 290.3 291.1       291.1   (0.8)
Other comprehensive income (loss), net of tax 13.7 13.7         13.7  
Common stock issued under stock and equity plans (in shares)     0.6          
Common stock issued under stock and equity plans 30.1 30.1 $ 0.6   29.5      
Stock-based compensation expense 41.2 41.2     41.2      
Purchases of treasury stock (in shares)       7.8        
Purchases of treasury stock (543.1) (543.1)   $ (593.1) 50.0      
Changes to noncontrolling interest (233.7) (173.3)     (173.3)     (60.4)
Common stock, ending balance (in shares) at Sep. 30, 2025     658.2          
Ending balance at Sep. 30, 2025 $ 10,205.0 10,205.0 $ 658.2 $ (7,049.5) 2,697.4 14,149.3 (250.4) 0.0
Treasury stock, ending balance (in shares) at Sep. 30, 2025       77.5        
Common stock, beginning balance (in shares) at Dec. 31, 2025 580.7   658.7          
Beginning balance at Dec. 31, 2025 $ 10,337.6 10,337.6 $ 658.7 $ (7,091.7) 2,768.4 14,240.5 (238.3) 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 78.0     78.0        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) $ 380.7 380.7       380.7    
Other comprehensive income (loss), net of tax 17.0 17.0         17.0  
Common stock issued under stock and equity plans (in shares)     1.3          
Common stock issued under stock and equity plans 69.0 69.0 $ 1.3   67.7      
Stock-based compensation expense 45.4 45.4     45.4      
Purchases of treasury stock (in shares)       5.0        
Purchases of treasury stock (522.2) (522.2)   $ (422.2) (100.0)      
Common stock, ending balance (in shares) at Mar. 31, 2026     660.0          
Ending balance at Mar. 31, 2026 $ 10,327.5 10,327.5 $ 660.0 $ (7,513.9) 2,781.5 14,621.2 (221.3) 0.0
Treasury stock, ending balance (in shares) at Mar. 31, 2026       83.0        
Common stock, beginning balance (in shares) at Dec. 31, 2025 580.7   658.7          
Beginning balance at Dec. 31, 2025 $ 10,337.6 10,337.6 $ 658.7 $ (7,091.7) 2,768.4 14,240.5 (238.3) 0.0
Treasury stock, beginning balance (in shares) at Dec. 31, 2025 78.0     78.0        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) $ 923.5              
Common stock, ending balance (in shares) at Sep. 30, 2026 575.6   662.3          
Ending balance at Sep. 30, 2026 $ 10,961.5 10,861.1 $ 662.3 $ (7,809.2) 3,057.6 15,170.6 (220.2) 100.4
Treasury stock, ending balance (in shares) at Sep. 30, 2026 86.7     86.7        
Common stock, beginning balance (in shares) at Mar. 31, 2026     660.0          
Beginning balance at Mar. 31, 2026 $ 10,327.5 10,327.5 $ 660.0 $ (7,513.9) 2,781.5 14,621.2 (221.3) 0.0
Treasury stock, beginning balance (in shares) at Mar. 31, 2026       83.0        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 241.4 241.9       241.9   (0.5)
Other comprehensive income (loss), net of tax 1.7 6.7         6.7 (5.0)
Common stock issued under stock and equity plans (in shares)     1.7          
Common stock issued under stock and equity plans 53.9 53.9 $ 1.7   52.2      
Stock-based compensation expense 42.2 42.2     42.2      
Purchases of treasury stock (in shares)       2.1        
Purchases of treasury stock (54.2) (54.2)   $ (154.2) 100.0      
Changes to noncontrolling interest 112.4             112.4
Common stock, ending balance (in shares) at Jun. 30, 2026     661.7          
Ending balance at Jun. 30, 2026 10,724.9 10,618.0 $ 661.7 $ (7,668.1) 2,975.9 14,863.1 (214.6) 106.9
Treasury stock, ending balance (in shares) at Jun. 30, 2026       85.1        
Increase (Decrease) in Stockholders' Equity                
Net income (loss) 301.4 307.5       307.5   (6.1)
Other comprehensive income (loss), net of tax (6.0) (5.6)         (5.6) (0.4)
Common stock issued under stock and equity plans (in shares)     0.6          
Common stock issued under stock and equity plans 36.3 36.3 $ 0.6   35.7      
Stock-based compensation expense 46.0 46.0     46.0      
Purchases of treasury stock (in shares)       1.6        
Purchases of treasury stock $ (141.1) (141.1)   $ (141.1)        
Common stock, ending balance (in shares) at Sep. 30, 2026 575.6   662.3          
Ending balance at Sep. 30, 2026 $ 10,961.5 $ 10,861.1 $ 662.3 $ (7,809.2) $ 3,057.6 $ 15,170.6 $ (220.2) $ 100.4
Treasury stock, ending balance (in shares) at Sep. 30, 2026 86.7     86.7